Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (306K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Klinge, C. M.
Right arrow Articles by Traish, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klinge, C. M.
Right arrow Articles by Traish, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 10 1903-1912, Copyright © 1997 by Oxford University Press


ARTICLES

Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro

CM Klinge, DL Bodenner, D Desai, RM Niles and AM Traish
Department of Biochemistry, the University of Louisville School of Medicine, Louisville, KY 40292, USA. cmklin01@ulkyvym.louisville.edu

The mechanism by which retinoids, thyroid hormone (T3) and estrogens modulate the growth of breast cancer cells is unclear. Since nuclear type II nuclear receptors, including retinoic acid receptor (RAR), retinoid X receptor (RXR) and thyroid hormone receptor (TR), bind direct repeats (DR) of the estrogen response elements (ERE) half-site (5'-AGGTCA-3'), we examined the ability of estrogen receptor (ER) versus type II nuclear receptors, i.e. RARalpha, beta and gamma, RXRbeta, TRalpha and TRbeta, to bind various EREs in vitro . ER bound a consensus ERE, containing a perfectly palindromic 17 bp inverted repeat (IR), as a homodimer. In contrast, ER did not bind to a single ERE half- site. Likewise, ER did not bind two tandem (38 bp apart) half-sites, but low ER binding was detected to three tandem copies of the same half- site. RARalpha,beta or gamma bound both ERE and half-site constructs as a homodimer. RXRbeta did not bind full or half-site EREs, nor did RXRbeta enhance RARalpha binding to a full ERE. However, RARalpha and RXRbeta bound a half-site ERE cooperatively forming a dimeric complex. The RARalpha-RXRbeta heterodimer bound the Xenopus vitellogenin B1 estrogen responsive unit, with two non-consensus EREs, with higher affinity than one or two copies of the full or half-site ERE. Both TRalpha and TRbeta bound the full and the half-site ERE as monomers and homodimers and cooperatively as heterodimers with RXRbeta. We suggest that the cellular concentrations of nuclear receptors and their ligands, and the nature of the ERE or half-site sequence and those of its flanking sequences determine the occupation of EREs in estrogen- regulated genes in vivo .
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. S. Carroll and M. Brown
Estrogen Receptor Target Gene: An Evolving Concept
Mol. Endocrinol., August 1, 2006; 20(8): 1707 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. C. Kwekel, L. D. Burgoon, J. W. Burt, J. R. Harkema, and T. R. Zacharewski
A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling
Physiol Genomics, November 17, 2005; 23(3): 327 - 342.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. M. Miller, K. W. Jarosinski, and K. A. Schat
Positive and Negative Regulation of Chicken Anemia Virus Transcription
J. Virol., March 1, 2005; 79(5): 2859 - 2868.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Tanmahasamut, J. Liu, L. B. Hendry, and N. Sidell
Conjugated Linoleic Acid Blocks Estrogen Signaling in Human Breast Cancer Cells
J. Nutr., March 1, 2004; 134(3): 674 - 680.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. L. Ramsey, K. E. Risinger, S. C. Jernigan, K. A. Mattingly, and C. M. Klinge
Estrogen Receptor {beta} Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner
Endocrinology, January 1, 2004; 145(1): 149 - 160.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. A. Krieg, A. J. Krieg, and D. J. Shapiro
A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1)
Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. M. Klinge
Estrogen receptor interaction with estrogen response elements
Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Holland, A. Norell, and P. Micevych
Interaction of Thyroxine and Estrogen on the Expression of Estrogen Receptor {alpha}, Cholecystokinin, and Preproenkephalin Messenger Ribonucleic Acid in the Limbic-Hypothalamic Circuit
Endocrinology, March 1, 1998; 139(3): 1221 - 1228.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Klinge, B. F. Silver, M. D. Driscoll, G. Sathya, R. A. Bambara, and R. Hilf
Chicken Ovalbumin Upstream Promoter-Transcription Factor Interacts with Estrogen Receptor, Binds to Estrogen Response Elements and Half-Sites, and Inhibits Estrogen-induced Gene Expression
J. Biol. Chem., December 12, 1997; 272(50): 31465 - 31474.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.